Top

Published in:

01-09-2017 | Case report

Nintedanib

Alterations in hepatic enzymes: case report

Published in: Reactions Weekly | Issue 1/2017

Excerpt

An observational retrospective study described a man [age not stated], who developed alterations in hepatic enzymes following treatment with nintedanib. The man, who had a history of idiopathic pulmonary fibrosis, started to receive nintedanib [route and dosage not stated]. He developed alterations in hepatic enzymes [duration of treatment to reaction onset and outcome not stated]. …

Rengifo MCD, et al. Experience with nintedanib for the treatment of idiopathic pulmonary fibrosis. European Journal of Hospital Pharmacy - Science and Practice 24: A118, Mar 2017. Available from: URL: http://ejhp.bmj.com/content/24/Suppl_1/A118.1 [abstract] - Spain

Title: Nintedanib
Alterations in hepatic enzymes: case report
Publication date: 01-09-2017
Publisher: Springer International Publishing
Published in: Reactions Weekly / Issue 1/2017
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-017-35764-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Nintedanib

Alterations in hepatic enzymes: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2017

Ipilimumab/nivolumab/pembrolizumab

Levothyroxine sodium

Etanercept

Yttrium-90

Dasatinib/nilotinib

Erlotinib/osimertinib